Press Releases Year All News | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | Dec 19, 2018 TCR² Therapeutics Announces Oncology Industry Leader and Expert Andrew Allen, M.D., Ph.D. Joins its Board of Directors Nov 29, 2018 TCR² Therapeutics wins U.S. Private Company of the Year Award at LifeStars Awards™ Life Sciences 2018 Event May 14, 2018 TCR² Therapeutics to Present at the UBS Global Healthcare Conference and the Jefferies 2018 Global Healthcare Conference Apr 12, 2018 TCR² Therapeutics to Present New Preclinical Data at the American Association for Cancer Research (AACR) 2018 Annual Meeting Apr 10, 2018 TCR² Therapeutics Appoints Leading Biotech Analyst Ian Somaiya as Chief Financial Officer Mar 21, 2018 TCR² Therapeutics Raises $125 Million in Oversubscribed Series B Financing Mar 06, 2018 TCR² Therapeutics to Present at the Cowen and Company 38th Annual Healthcare Conference and Needham & Company 17th Annual Healthcare Conference Feb 05, 2018 TCR² Therapeutics to Present at the 2018 Keystone Symposia Conference on Emerging Cellular Therapies: T Cells and Beyond Jan 03, 2018 TCR² Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
